693288-95-8 Usage
Benzamide derivative
It is a compound derived from benzoic acid The benzamide is formed by the substitution of the carboxyl group (-COOH) in benzoic acid with an amide group (-CONH2).
Chloro substituent
A chlorine atom (Cl) attached to the benzene ring The presence of the chlorine atom at the para position (4th position) of the benzene ring influences the compound's reactivity, polarity, and pharmacological activity.
Methyl group
A methyl group (-CH3) attached to the benzene ring The methyl group is present at the ortho position (2nd position) of the benzene ring, which affects the compound's steric hindrance and electronic properties.
Pharmaceutical industry application
Anti-inflammatory and analgesic properties The compound is used in the pharmaceutical industry for its potential therapeutic effects, such as reducing inflammation and relieving pain.
Potential ingredient in new medications
Treatment of various medical conditions Due to its structure and properties, 2-(acetyloxy)-N-(4-chloro-2-methylphenyl)Benzamide may be an important component in the development of new drugs for treating a range of medical conditions.
Research and development applications
Organic chemistry and drug discovery The compound may also be useful in research and development within the fields of organic chemistry and drug discovery, potentially leading to the identification of new therapeutic agents.
Check Digit Verification of cas no
The CAS Registry Mumber 693288-95-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,9,3,2,8 and 8 respectively; the second part has 2 digits, 9 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 693288-95:
(8*6)+(7*9)+(6*3)+(5*2)+(4*8)+(3*8)+(2*9)+(1*5)=218
218 % 10 = 8
So 693288-95-8 is a valid CAS Registry Number.
693288-95-8Relevant articles and documents
A Novel Selective Allosteric Modulator Potentiates the Activity of Native Metabotropic Glutamate Receptor Subtype 5 in Rat Forebrain
O'Brien, Julie A.,Lemaire, Wei,Wittmann, Marion,Jacobson, Marlene A.,Ha, Sookhee N.,Wisnoski, David D.,Lindsley, Craig W.,Schaffhauser, Herve J.,Rowe, Blake,Sur, Cyrille,Duggan, Mark E.,Pettibone, Douglas J.,Conn, P. Jeffrey,Williams Jr., David L.
, p. 568 - 577 (2004)
We found that N-{4-chloro-2-[(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)methyl]phenyl} -2-hydroxybenzamide (CPPHA), is a potent and selective positive allosteric modulator of the metabotropic glutamate receptor subtype 5 (mGluR5). CPPHA alone had no agonist
